Rob Roscow on Reimagining Psilocybin, Mental Health Treatments, and Addictions
Executive Health and Life · Julian Hayes II
July 4, 202231m 58s
Audio is streamed directly from the publisher (anchor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
We have Co-Founder & Chief Scientific Officer at Mydecine Innovations Group, Rob Roscow, stopping by to discuss creating novel therapeutic options for various mental health issues and addictions. Mydecine has government, military, and academic research contracts across numerous countries and is heavily invested in developing a novel molecule pipeline that includes treatments intended for smoking cessation and treatment of PTSD.
Connect with Robb
- Website — https://mydecine.com/
Connect with Julian
- Book your Executive Health Game Planning Call: https://theartoffitnessandlife.com/us/ or email julian@theartoffitnessandlif e.com
- Connect with me on Twitter: https://twitter.com/thejulianhayes
- Connect with me on LinkedIn: https://www.linkedin.com/in/julianhayes